Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Complement 1
Complement 1 is a health technology company dedicated to transforming cancer care through lifestyle medicine. Founded in 2024 and headquartered in Dover, Delaware, the company offers a clinically validated, tech-enabled lifestyle program that provides daily one-on-one coaching for cancer patients, survivors, and those at high risk. Their platform integrates personalized coaching with evidence-based interventions in exercise, nutrition, and somatic practices to improve patients' quality of life. Complement 1 collaborates with leading oncologists and seamlessly integrates with conventional oncology care to deliver better outcomes and empower patients in their healing journey. The company's mission is to make effective, holistic cancer care accessible to all.
- Sector: Health Care
- Last known transaction date: Seed Venture, $16M, May 2025
- Why timing suggests a near-term transaction: A $16M seed round in May 2025 is a relatively large seed raise for a healthcare company, providing roughly 18–24 months of runway, but the elevated regulatory, clinical, and development costs in the sector drive steady capital consumption — placing Complement 1 in the active fundraising window for a Series A by late 2026 to early 2027 as early proof-of-concept data or platform validation from the seed period provide the milestones needed to attract institutional growth capital.
View all private company data in Dakota Marketplace.
2. Certify Health
Certify Health is a healthcare technology company specializing in patient engagement and biometric authentication solutions. Founded in Gaithersburg, Maryland, the company offers a Software as a Service (SaaS) platform that integrates biometric technologies to verify patient identities, enhancing the security and efficiency of healthcare interactions. Their services include patient appointment scheduling, digital intake processes, and communication tools designed to streamline patient journeys and improve overall healthcare delivery. The leadership team comprises CEO Marc Potash, COO Jacob Saji, and CTO Preetham Gowda. Certify Health's strategic objectives focus on expanding their biometric authentication services across healthcare organizations to enhance patient experience and operational efficiency.
- Sector: Information Technology
- Last known transaction date: Series A Venture, Undisclosed, May 2025
- Why timing suggests a near-term transaction: An undisclosed Series A in May 2025 for a health IT company typically implies a raise in the $5–20M range, providing roughly 18–24 months of runway — placing Certify Health in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate the platform adoption, customer retention, and revenue growth metrics that growth-stage investors require to underwrite a larger round in the competitive health technology market.
View all private company data in Dakota Marketplace.
3. WakeCap
WakeCap Technologies is a Dubai-based company specializing in IoT-driven solutions to enhance safety and productivity on construction sites. Their sensor-powered project control system offers real-time workforce visibility and site-wide intelligence, serving major clients like NEOM, ARAMCO, and Qiddiya.
- Sector: Industrials
- Last known funding round: Series A Venture, $28M, May 2025
- Why timing suggests a near-term transaction: A $28M Series A in May 2025 provides roughly 18–24 months of runway for an industrials technology company, where enterprise sales cycles, hardware deployment costs, and customer implementation timelines drive steady capital consumption — placing WakeCap in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate scaled commercial deployments, recurring revenue growth, and the operational traction that growth-stage investors require.
View all private company data in Dakota Marketplace.
4. Stylus Medicine
Stylus Medicine is a biotechnology company specializing in developing in vivo genetic medicines using engineered recombinases to deliver therapeutic payloads with high precision. Their platform aims to provide targeted gene editing in vivo, enabling the insertion of genetic sequences into the human genome to develop permanent cures for patients.
- Sector: Health Care
- Last known funding round: Series A Venture, $85M, May 2025
- Why timing suggests a near-term transaction: A $85M Series A in May 2025 is a substantial raise for a healthcare company, typically supporting 24–36 months of clinical-stage runway, but the scale of investment also signals an aggressive development timeline with elevated burn across clinical trials, regulatory activities, and platform advancement — positioning Stylus Medicine in the active fundraising window for a Series B by late 2026 to mid-2027 as key clinical milestones and data readouts from the Series A period provide the proof points needed to support a larger growth-stage round.
View all private company data in Dakota Marketplace.
5. Penzilla
Penzilla is a Munich-based HRTech startup founded in 2021, specializing in digitizing and simplifying the management of occupational pension schemes (bAV) for companies. Their Software-as-a-Service (SaaS) platform automates administrative tasks, ensures legal compliance, and integrates seamlessly with existing HR systems, providing a transparent and efficient solution for both employers and employees.
- Sector: Information Technology
- Last known funding round: Seed Venture, $3.6M, May 2025
- Why timing suggests a near-term transaction: A $3.6M seed round in May 2025 provides a lean 12–15 month runway for an IT company, where product development, engineering talent, and early go-to-market costs accumulate quickly — suggesting Penzilla is very likely already in active fundraising conversations for a Series A and could be seeking to close a round by mid-to-late 2026 before runway constraints become critical.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
